LORDSMARK
1 call
Concalls & earnings callsLords Mark Industries Ltd
Every summarised call, newest first. Latest is Q1 FY27, held 10 Sept 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →Lords Mark Industries presented its renewable energy and MedTech businesses and guided to around 1550 crores of consolidated revenue in FY 27 with growth from diagnostics, dialysis and new product commercialization.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| FY 27 consolidated revenue guidance | 1550 crores | — | |
| FY 27 EBITDA margin guidance | 20.8% | — | |
| FY 27 PAT margin guidance | 12.8% | — | |
| Full-year consolidated revenue | 1290 crores | — |
Latest guidance
- FY 27 consolidated revenue guidance of around 1550 crores
- FY 27 EBITDA of around 20.8% and PAT of around 12.8%
- FY 28 consolidated top line expected to cross around 2100 crores with EBITDA expected to be around 23-24%
- Segment FY 27 revenue of around 825 crores from IVD, MedTech and dialysis with balance from renewable energy
- Operate 50 dialysis centers by March 27 with 15 of them already operational
- Export revenue contribution to reach 10% of total revenue by June 27
Said on the Q1 FY27 call.
Call history
- Q1 FY27Positive tone
Lords Mark Industries presented its renewable energy and MedTech businesses and guided to around 1550 crores of consolidated revenue in FY 27 with growth from diagnostics, dialysis and new product commercialization.
- FY 27 consolidated revenue guidance
- 1550 crores
- FY 27 EBITDA margin guidance
- 20.8%